Issue navigation
Volume 21, Issue 5, 1 May 2015
Letters to the Editor
Can Fecal Calprotection Identify Postoperative Recurrence of Crohn's Disease?
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Page E7, https://doi.org/10.1097/MIB.0000000000000390
Reply to Can Fecal Calprotection Identify Postoperative Recurrence of Crohn's Disease?
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Page E7, https://doi.org/10.1097/MIB.0000000000000416
Original Articles
Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 963–972, https://doi.org/10.1097/MIB.0000000000000332
Neutralizing IL-23 Is Superior to Blocking IL-17 in Suppressing Intestinal Inflammation in a Spontaneous Murine Colitis Model
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 973–984, https://doi.org/10.1097/MIB.0000000000000353
Photodynamic Therapy Relieves Colitis and Prevents Colitis-associated Carcinogenesis in Mice
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 985–995, https://doi.org/10.1097/MIB.0000000000000354
A MicroRNA Signature in Pediatric Ulcerative Colitis: Deregulation of the miR-4284/CXCL5 Pathway in the Intestinal Epithelium
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 996–1005, https://doi.org/10.1097/MIB.0000000000000339
Hydrogen Sulfide Protects from Colitis and Restores Intestinal Microbiota Biofilm and Mucus Production
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1006–1017, https://doi.org/10.1097/MIB.0000000000000345
Escherichia coli LF82 Differentially Regulates ROS Production and Mucin Expression in Intestinal Epithelial T84 Cells: Implication of NOX1
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1018–1026, https://doi.org/10.1097/MIB.0000000000000365
Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1027–1037, https://doi.org/10.1097/MIB.0000000000000346
Reducing Colorectal Anastomotic Leakage with Tissue Adhesive in Experimental Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1038–1046, https://doi.org/10.1097/MIB.0000000000000336
Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1047–1053, https://doi.org/10.1097/MIB.0000000000000359
Relationship Between Azathioprine Dosage, 6-Thioguanine Nucleotide Levels, and Therapeutic Response in Pediatric Patients with IBD Treated with Azathioprine
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1054–1062, https://doi.org/10.1097/MIB.0000000000000347
Exercise Decreases Risk of Future Active Disease in Patients with Inflammatory Bowel Disease in Remission
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1063–1071, https://doi.org/10.1097/MIB.0000000000000333
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1072–1076, https://doi.org/10.1097/MIB.0000000000000349
Alpha-1 Antitrypsin and Granulocyte Colony-stimulating Factor as Serum Biomarkers of Disease Severity in Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1077–1088, https://doi.org/10.1097/MIB.0000000000000348
Are Patients with Inflammatory Bowel Disease on Chronic Immunosuppressive Therapy at Increased Risk of Cervical High-grade Dysplasia/Cancer? A Meta-analysis
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1089–1097, https://doi.org/10.1097/MIB.0000000000000338
Presentation and Progression of Childhood-Onset Inflammatory Bowel Disease in Northern Stockholm County
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1098–1108, https://doi.org/10.1097/MIB.0000000000000356
Management of Intra-abdominal Abscesses in Children With Crohn's Disease: A 12-year, Retrospective Single-center Review
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1109–1114, https://doi.org/10.1097/MIB.0000000000000361
PedsQL Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients with Inflammatory Bowel Disease in Comparison with Healthy Controls
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1115–1124, https://doi.org/10.1097/MIB.0000000000000351
Transition Readiness Skills Acquisition in Adolescents and Young Adults with Inflammatory Bowel Disease: Findings from Integrating Assessment into Clinical Practice
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1125–1131, https://doi.org/10.1097/MIB.0000000000000352
Future Directions and Methods for IBD Research
Blood-based Biomarkers Used to Predict Disease Activity in Crohn's Disease and Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1132–1140, https://doi.org/10.1097/MIB.0000000000000340
Intestinal Fibrosis in Crohn's Disease: Role of microRNAs as Fibrogenic Modulators, Serum Biomarkers, and Therapeutic Targets
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1141–1150, https://doi.org/10.1097/MIB.0000000000000298
Cochrane Review
Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1151–1159, https://doi.org/10.1097/MIB.0000000000000396
Basic Science Review Article
MicroRNAs in Inflammatory Bowel Diseases: Paradoxes and Possibilities
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1160–1165, https://doi.org/10.1097/MIB.0000000000000288
Very Early-onset Inflammatory Bowel Disease: Gaining Insight Through Focused Discovery
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1166–1175, https://doi.org/10.1097/MIB.0000000000000329
Clinical Review Article
Immune-mediated Reactions to Anti-tumor Necrosis Factors in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1176–1186, https://doi.org/10.1097/MIB.0000000000000279
Impact of Drug Therapy and Surgery on Quality of Life in Crohn's Disease: A Systematic Review
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1187–1194, https://doi.org/10.1097/MIB.0000000000000271
Overview of Venous Thrombosis in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1195–1203, https://doi.org/10.1097/MIB.0000000000000274
Prevention and Treatment of Venous Thromboembolism in Patients with IBD: A Trail Still Climbing
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1204–1213, https://doi.org/10.1097/MIB.0000000000000310
Hispanics and Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 21, Issue 5, 1 May 2015, Pages 1214–1218, https://doi.org/10.1097/MIB.0000000000000300
